Taisho Pharmaceutical Co., Ltd.: all 53 studies

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal DialysisRecruitingNCT07548853Phase 3
• A Long-term Study of TS-172 in Hyperphosphatemia Patients on HemodialysisRecruitingNCT07285304Phase 3
• A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate BindersRecruitingNCT07285291Phase 3
• A Pharmacokinetic Study of TS-172 in Patients With Hepatic ImpairmentRecruitingNCT07231029Phase 1
• A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive DisorderTerminatedNCT03093025Phase 2Results posted
• Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)CompletedNCT00914186Phase 2Results posted
• A Clinical Study of TS-172 in Hyperphosphatemia Patients on HemodialysisActive, not recruitingNCT07548840Phase 3
• Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner PopulationCompletedNCT07482046Phase 2/3
• Counterpain PXM Versus Diclofenac Versus PiroxicamCompletedNCT07475663Phase 3
• A Pharmacodynamic Study of TS-172 in Healthy Adult Male SubjectsCompletedNCT07084961Phase 1
• An Open-label Pharmacokinetic Study of TS-172 in Patients on HemodialysisCompletedNCT06849778Phase 1
• A QT/QTc Evaluation Study of TS-172 in Healthy Adult SubjectsCompletedNCT06837155Phase 1
• A Drug-drug Interaction Study With TS-172 in Healthy Adult Male SubjectsCompletedNCT06837142Phase 1
• A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on HemodialysisCompletedNCT06745531Phase 3
• A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate BindersCompletedNCT06745518Phase 2
• A Mass Balance Study of TS-172 in Healthy Adult SubjectsCompletedNCT06596356Phase 1
• A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly SubjectsCompletedNCT05819710Phase 1
• A Food Effect Study of TS-142 in Healthy SubjectsCompletedNCT05707897Phase 1
• A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on HemodialysisCompletedNCT05699239Phase 2
• A Pharmacokinetic Study of TS-142 in Patients with Hepatic ImpairmentCompletedNCT05624944Phase 1
• Long-Term Study of TS-142 in Patients with InsomniaCompletedNCT05461352Phase 3
• Phase III Study of TS-142 in Patients with InsomniaCompletedNCT05453136Phase 3
• A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)CompletedNCT04979572Phase 1
• A QT/QTc Evaluation Study of TS-142 in Healthy Adult SubjectsCompletedNCT04873323Phase 1
• Mass Balance Study of TS-142 in Healthy Adult Subjects.CompletedNCT04814771Phase 1
• A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.CompletedNCT04746105Phase 1
• A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy SubjectsCompletedNCT04696952Phase 1
• Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult SubjectsCompletedNCT04631276Phase 1
• Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia DisorderCompletedNCT04573725Phase 2
• Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole)CompletedNCT04557163Phase 1
• Late Phase II Study of TS-142 in Patients with InsomniaCompletedNCT04469023Phase 2
• A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy ParticipantsCompletedNCT04464239Phase 1
• A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)CompletedNCT04169906Phase 1
• A Phase I Study of TS-142 in Healthy Participants (Single Doses)CompletedNCT04169893Phase 1
• Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive ControlCompletedNCT04108351Not applicable
• Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy SubjectsCompletedNCT04087707Phase 2
• An Extension Study of TS-152 in Subjects with Rheumatoid ArthritisCompletedNCT04077567Phase 3
• First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy ParticipantsCompletedNCT03919409Phase 1
• Safety, Tolerability and Pharmacokinetics of Single Doses of TS-134 in Healthy VolunteersCompletedNCT03746067Phase 1
• Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy VolunteersCompletedNCT03742791Phase 1
• Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)CompletedNCT03595202Phase 1
• Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)CompletedNCT03591133Phase 1
• Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients with Chronic Kidney DiseaseCompletedNCT03581071Phase 1
• Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3CompletedNCT03572985Not applicable
• Safety and Efficacy of SFPP in Knee OsteoarthritisCompletedNCT03434197Phase 3
• Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #2CompletedNCT03413592Not applicable
• Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1CompletedNCT03278080Not applicable
• A Study to Evaluate the Safety and Efficacy of TS-091 in Patients with NarcolepsyCompletedNCT03267303Phase 2
• Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy SubjectsCompletedNCT03141658Phase 1
• Exploratory Study Using Positron Emission Tomography With TS-121 and [11C]TASP0410699 in Healthy Adult Male SubjectsCompletedNCT02448212Phase 1
• Multiple Dose Safety Study of PF-04802540 in Subjects With SchizophreniaCompletedNCT00876304Phase 1
• A Study Of The Effect Of PF-04802540 On Sleep MeasuresCompletedNCT00772512Phase 1
• Multiple Dose Safety Study of PF-04802540 in Healthy VolunteersCompletedNCT00756743Phase 1

← Taisho Pharmaceutical Co., Ltd. overview and focus areas